Our Daughters—Ourselves: Evaluating the Impact of Paired Cervical Cancer Screening of Mothers with HPV Vaccination for Daughters to Improve HPV Vaccine Coverage in Bamako, Mali
Author:
Crippin Tiffani1, Tounkara Karamoko2, Munir Hayley3ORCID, Squibb Eliza1, Piotrowski Caroline4, Koita Ousmane A.5, Teguété Ibrahima6, De Groot Anne S.1
Affiliation:
1. GAIA Vaccine Foundation, Providence, RI 02909, USA 2. GAIA Vaccine Foundation, Bamako 999053, Mali 3. Criminal Justice Sciences Faculty, Illinois State University, Normal, IL 61761, USA 4. Department of Infectious Diseases, University of Georgia, Athens, GA 30602, USA 5. Laboratory of Applied Molecular Biology, University of Sciences, Techniques, and Technologies, Bamako 999053, Mali 6. Gabriel Touré Teaching Hospital, Bamako 999053, Mali
Abstract
Cervical cancer (CC) is the second most common cancer in Western Africa, accounting for 12,000 cases and 6000 deaths annually. While vaccination against human papilloma virus (HPV) and CC screenings reduce the incidence and mortality of CC in many developed countries, 90% of CC deaths are in low-income countries. Lack of knowledge about the connection between HPV and CC, lack of access to vaccines and screenings, weak healthcare infrastructure, and stigma related to sexually transmitted diseases are among the factors that contribute to this disparity. Previously, we evaluated the knowledge of HPV and CC in Bamako, Mali, showing that knowledge of the link between HPV and CC was very low (less than 8% of participants) and that less than 3% of women were screened for CC. Subsequent implementation of a community-based education program and support for local clinics resulted in a five-fold increase in CC screening at the five participating clinics in 2015. In this study, we paired CC screenings of mothers with HPV vaccination of their daughters to target out-of-school (OOS) girls whom school-based vaccination campaigns would not reach. Our campaign resulted in a 10.7% increase in HPV vaccination.
Funder
Investigator-Initiated Studies Program of Merck Sharp & Dohme LLC
Reference34 articles.
1. Lekoane, K.M.B., Kuupiel, D., Mashamba-Thompson, T.P., and Ginindza, T.G. (2019). Evidence on the prevalence, incidence, mortality and trends of human papilloma virus-associated cancers in sub-Saharan Africa: Systematic scoping review. BMC Cancer, 19. 2. Bruni, L., Albero, G., Serrano, B., Mena, M., Collado, J.J., Gómez, D., Muñoz, J., Bosch, F.X., and de Sanjosé, S. (2023). Human Papillomavirus and Related Diseases in Mali Report 10 March 2023, ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). 3. Ferlay, J., Ervik, M., Lam, F., Laversanne, M., Colombet, M., Mery, L., Piñeros, M., Znaor, A., Soerjomataram, I., and Bray, F. (2024, August 28). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available online: https://gco.iarc.who.int/today,. 4. Worldwide trends in cervical cancer incidence: Impact of screening against changes in disease risk factors;Vaccarella;Eur. J. Cancer,2013 5. Cervical cancer screening in Mali: Eight years of experience and perspectives;Teguete;J. SAGO,2008
|
|